Smac mimetic dimers and trimers useful as anti-cancer agents

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 207/16 (2006.01) A61K 31/4025 (2006.01) A61P 29/00 (2006.01) A61P 35/00 (2006.01) A61P 37/00 (2006.01) C07D 249/04 (2006.01) C07D 401/14 (2006.01) C07D 403/04 (2006.01) C07D 403/14 (2006.01) C07D 405/14 (2006.01) C07D 409/14 (2006.01) C07D 487/14 (2006.01)

Patent

CA 2684169

The invention provides small molecule mimics of the SMAC peptide that are dimer-like or trimer-like compounds having two or three amide-containing domains connected by a linker. These compounds are useful to promote apoptosis. The invention includes pharmaceutical compositions comprising such compounds and methods to use them to treat conditions including cancer and autoimmune disorders.

L'invention concerne des mimétiques de petites molécules du peptide SMAC qui sont des composés de type dimère ou de type trimère ayant deux ou trois domaines contenant un amide reliés par un lieur. Ces composés sont utiles pour favoriser l'apoptose. L'invention comprend des compositions pharmaceutiques comprenant de tels composés et des procédés pour les utiliser dans le but de traiter des affections comprenant le cancer et les maladies auto-immunes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Smac mimetic dimers and trimers useful as anti-cancer agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Smac mimetic dimers and trimers useful as anti-cancer agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Smac mimetic dimers and trimers useful as anti-cancer agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1768495

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.